Navigation Links
012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007
Date:2/26/2008

14% increase in core broadband activities.

Note: pro-forma results are provided to assist the reader in comparing the Company's 2007 results, which include the full contribution of its merger with 012 Golden Lines, with 2006 results, which were before the merger. Pro-forma results combine 012 Golden Lines' results for 2006 with Smile.Communications' results for the same period, together with certain adjustments made according to U.S. GAAP (Generally Accepted Accounting Principles) to give effect to the Company's acquisition of 012 Golden Lines, including amortization and financial expenses resulting from the acquisition, as if it occurred on January 1, 2006.

Adjusted EBITDA(A) for 2007 increased by 24% to NIS 237.1 million ($61.6) million compared with NIS 191.7 million in 2006 on a pro-forma basis. Adjusted EBITDA margin for the year was 22% compared with 18% in 2006 on a pro-forma basis.

Net income for the full year December 31, 2007 was NIS 41.0 million ($10.7 million), or NIS 2.10 ($0.55) per share, compared with a net loss of NIS 2.0 million, or NIS 0.11 per share, for 2006. On a pro-forma basis, the Company recorded a net loss of NIS 12.1 million, or NIS 0.55 per share, for 2006, reflecting adjustments made in accordance to U.S. GAAP to give effect to amortization and financial expenses resulting from the Company's acquisition of 012 Golden Lines.

For a detailed reconciliation of GAAP to non-GAAP financial information and for more information regarding the use of non-GAAP financial measures, please see the table titled "Reconciliation Table of Non-GAAP Measures" as well as the notes contained in this press release.

Results for the Fourth Quarter

Revenues for the fourth quarter of 2007 were NIS 271.3 million ($70.5 million) a 179% increase compared with NIS 97.1 million for the fourth quarter of 2006, and a 3% decrease compared with pro-forma revenues for the fourth quarter of 2006. Excluding revenues from hubbing traff
'/>"/>

SOURCE 012 Smile.communications Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. 012 Smile.Communications to Deploy Extensive WiFi Internet Access System for Sheba Medical Center
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. Haemacure Reports Third Quarter 2007 Results
4. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
5. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
6. MDS Reports Third Quarter 2007 Results
7. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
8. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
9. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
10. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
11. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Nov.25/PRNewswire/--TheBayAreaAirQualityManagement... the Air Alert forThursday,November26,20...hersolidfuel,bothindoorsandoutdoors. ,, "Cold,s...rrow,"saidJackBroadbent,executiveofficeroftheAirDi...lthoftheirneighborsandfellowcommunitymembersthisTh...
(Date:11/25/2009)...e blood pressure? This simple question has been t...Stress-related gene Modulates High Blood Pressure ...e? This simple question has been the focus of int...s for the first time established a link between a ...onse to stress in mice as well as humans. The stud...
(Date:11/25/2009)...ed by neurological symptoms, study finds , ...logical side effects are among the potential probl...cer who were treated with cisplatin-based chemothe...ed 1,409 Norwegian men treated for unilateral test...in a follow-up survey conducted from 1998 to 2002....
(Date:11/25/2009)... A cancer vaccine carried into the body on a caref...irst to successfully eliminate tumors in mammals, ...e Translational Medicine . , The new approach, p...ard University, uses plastic disks impregnated wit...skin to reprogram the mammalian immune system to a...
(Date:11/25/2009)... Nationwide Imaging Services, known as one of ...agnostic imaging equipment, now offering a total s...ing options, service and installation with acquisi...chnologies of California) , ...de Imaging Services is proud to announce its acqui...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3
...skAnalyzer Incorporates Johns Hopkins ACG System f...ce Management and Rate Adjustment , , BIRMINGHAM,...ounced the launch of its new Medicare risk adjustm... the Centers for Medicare and Medicaid Services Hi...
... Sixteen QHR hospital client...million in February. The payments - ranging from ...ospital clients participating in a unique and inno...am, hospital groups that experience less than proj...
...he cadherin superfamily has a correlate relationsh...It has been suggested that, unlike E-cadherin, N-c...noma cells. To explore clinical pathological signi...tected the expression of E-cadherin and N-cadherin...
...oughly 100,000 Swedes are under treatment with the...ng sensitivity to Waran, which makes the initiatio...rhaging and clotting. Now researchers at Uppsala... England Journal of Medicine . , Some 20 researc...
...RCHASE, N.Y., Feb. 19 The PepsiCo Foundation toda... the Children to help ensure the survival and well...adesh, which together are home to 40 percent of th...on, Save the Children will work towards decreasing...
...N DIEGO, Feb. 19 Cardium Therapeutics (NYSE Alter...ompliance plan submitted on January 23, 2009 has b...y the American Stock Exchange). , , (Logo: ht...rrent listing exchange indicating that the company...
Other Medicine News:Health News:DST Health Solutions Launches New RiskAnalyzer Software to Help Medicare Advantage Plans Manage Risk Adjustment 2Health News:DST Health Solutions Launches New RiskAnalyzer Software to Help Medicare Advantage Plans Manage Risk Adjustment 3Health News:QHR, Gallagher Partnership Yields More Thank $4 Million for QHR Hospital Clients 2Health News:Knowledge of genetics improves uncertain medication 2Health News:PepsiCo Foundation Announces Grant to Save the Children to Address Malnutrition in Developing Nations 2Health News:PepsiCo Foundation Announces Grant to Save the Children to Address Malnutrition in Developing Nations 3Health News:Cardium's Exchange Listing Compliance Plan Accepted by NYSE Alternext US 2Health News:Cardium's Exchange Listing Compliance Plan Accepted by NYSE Alternext US 3Health News:Cardium's Exchange Listing Compliance Plan Accepted by NYSE Alternext US 4Health News:Cardium's Exchange Listing Compliance Plan Accepted by NYSE Alternext US 5
(Date:11/25/2009)...s.,Nov.25/PRNewswire-FirstCall/--Hologic,Inc.(Holo...manufacturerandsupplierofpremiumdiagnostics,medica...ngthehealthcareneedsofwomen,isusingtheannualmeetin...ormickPlaceinChicago,November29throughDecember3,20...ydiagnosticmammographyworkstationsoftware. ,, T...
(Date:11/25/2009)...A,Nov.25/PRNewswire-FirstCall/--ERT(Nasdaq: ERES )...,sPresidentandCEO,andKeithSchneck,theCompany,sExec...e21stAnnualPiperJaffrayHealthCareConferenceat1:30P...nterestedpartiesmayaccessthepresentationbyvisiting....Thewebcastmayalsobeaccessedat http://www.corporat...
(Date:11/25/2009)...ov.25/PRNewswire/--BioTrendsResearchGroup,Inc.rele...rt,thefirstinamulti-phasesyndicatedmarketresearchp...elara,fromproductlaunchthroughthefirstsixmonthsofa...einformationfrom75uniqueDermatologistsandqualitati...anduseofStelara,obstaclestouse,typicalpatienttypes...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Kensey Nash Corporation Adopts Stockholder Rights Plan 49456 1Kensey Nash Corporation Adopts Stockholder Rights Plan 49456 2Kensey Nash Corporation Adopts Stockholder Rights Plan 49456 3Kensey Nash Corporation Adopts Stockholder Rights Plan 49456 4Photos 3A Soccer Hall of Famer Marcelo Balboa Encourages Men to Team Up Against Prostate Cancer 49454 1Photos 3A Soccer Hall of Famer Marcelo Balboa Encourages Men to Team Up Against Prostate Cancer 49454 2Photos 3A Soccer Hall of Famer Marcelo Balboa Encourages Men to Team Up Against Prostate Cancer 49454 3Photos 3A Soccer Hall of Famer Marcelo Balboa Encourages Men to Team Up Against Prostate Cancer 49454 4White House Health Reform Stakeholder Discussion Brings Palliative Care to the Table 49451 1White House Health Reform Stakeholder Discussion Brings Palliative Care to the Table 49451 2
...7 /PRNewswire/ -- Asenapine -- an,investigational ...are business unit of Akzo Nobel, for bipolar I dis...more effective than placebo,in treating acute mani...order, according to new Phase III results, from a ...ation,s 2007 Annual,Meeting. , In the three-week s...
...7 APA Meeting -, COLLEGEVILLE, Pa., May 21, 2007 /...s examining safety and efficacy of,desvenlafaxine ...ibitor (SNRI) being studied as a potential treatme..., were presented today at the,2007 American Psychi...if., by Wyeth Pharmaceuticals, a division of Wyeth...
Other Medicine Technology:Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 2Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 3Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 3New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 5New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 7New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 8
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: